HLF — what changed in the latest 10-Q
A section-by-section comparison of HLF's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-05 vs the prior 10-Q · 2026-05-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +41 | −35 | ~41 | 49 |
| Market risk (Item 3) | Text added/removed | +4 | −3 | ~7 | 4 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 25 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-05
Our “other expense, net” consists of non-operating income and expenses such as gains or losses on extinguishment of debt.
Net sales were $1,326.8 million and $2,644.0 million for the three and six months ended June 30, 2026, respectively. Net sales increased $67.7 million, or 5.4%, and $163.2 million, or 6.6%, for the three and six months ended June 30, 2026, respectively, as compared to the same periods in 2025. In lo…
Net loss attributable to Herbalife was $26.3 million, or $0.25 per diluted share, and net income attributable to Herbalife was $35.6 million, or $0.33 per diluted share, for the three and six months ended June 30, 2026, respectively. Net income attributable to Herbalife decreased $75.6 million, or 1…
Net income attributable to Herbalife for the six months ended June 30, 2026 included a $94.6 million pre-tax unfavorable impact ($74.6 million post-tax) of loss on debt extinguishment from our April 2026 debt refinancing, $8.7 million favorable deferred income tax impacts relating to the changes in …
Net income attributable to Herbalife for the six months ended June 30, 2025 included $12.9 million favorable deferred income tax impacts relating to the changes in the Company’s corporate entity structure in 2024, a $4.0 million pre-tax unfavorable impact ($2.9 million post-tax) of Restructuring Pro…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
Net sales were $1,317.2 million for the three months ended March 31, 2026. Net sales increased $95.5 million, or 7.8%, for the three months ended March 31, 2026, as compared to the same period in 2025. In local currency, net sales increased 5.4% for the three months ended March 31, 2026, as compared…
Net income attributable to Herbalife was $61.9 million, or $0.57 per diluted share, for the three months ended March 31, 2026. Net income attributable to Herbalife increased $11.5 million, or 22.8%, for the three months ended March 31, 2026 as compared to the same period in 2025. The increase in net…
The Primary Reporting Segment reported contribution margin of $543.9 million, or 43.2% of net sales, for the three months ended March 31, 2026, representing an increase of $44.1 million, or 8.8%, as compared to the same period in 2025. The 8.8% increase in contribution margin for the three months en…
China reported contribution margin of $20.4 million for the three months ended March 31, 2026, representing a decrease of $2.9 million, or 12.4%, for the three months ended March 31, 2026, as compared to the same period in 2025. The 12.4% decrease in contribution margin for the three months ended Ma…
The North America region reported net sales of $247.6 million for the three months ended March 31, 2026. Net sales decreased $6.8 million, or 2.7%, for the three months ended March 31, 2026, as compared to the same period in 2025. In local currency, net sales decreased 2.8% for the three months ende…
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-08-05
In April 2026, the 2029 Secured Notes were fully redeemed. As of December 31, 2025, the fair value of the 2029 Secured Notes was approximately $888.1 million and the carrying value was $774.1 million. The 2029 Secured Notes paid interest at a fixed rate of 12.250% per annum payable semiannually in a…
As of June 30, 2026, the fair value of the 2033 Secured Notes was approximately $816.2 million and the carrying value was $785.7 million. The 2033 Secured Notes pay interest at a fixed rate of 7.750% per annum payable semiannually in arrears on May 1 and November 1 of each year, beginning on Novembe…
As of June 30, 2026, the fair value of the 2028 Convertible Notes was approximately $320.3 million and the carrying value was $274.2 million. As of December 31, 2025, the fair value of the 2028 Convertible Notes was approximately $301.7 million, and the carrying value was $273.4 million. The 2028 Co…
As of June 30, 2026, the fair value of the 2029 Notes was approximately $562.9 million and the carrying value was $596.8 million. As of December 31, 2025, the fair value of the 2029 Notes was approximately $565.6 million and the carrying value was $596.3 million. The 2029 Notes pay interest at a fix…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
As of March 31, 2026, the fair value of the 2029 Secured Notes was approximately $898.4 million and the carrying value was $775.7 million. As of December 31, 2025, the fair value of the 2029 Secured Notes was approximately $888.1 million and the carrying value was $774.1 million. The 2029 Secured No…
As of March 31, 2026, the fair value of the 2028 Convertible Notes was approximately $331.0 million and the carrying value was $273.8 million. As of December 31, 2025, the fair value of the 2028 Convertible Notes was approximately $301.7 million, and the carrying value was $273.4 million. The 2028 C…
As of March 31, 2026, the fair value of the 2029 Notes was approximately $563.2 million and the carrying value was $596.6 million. As of December 31, 2025, the fair value of the 2029 Notes was approximately $565.6 million and the carrying value was $596.3 million. The 2029 Notes pay interest at a fi…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice